Congress Materials – American Society of Clinical Psychopharmacology (ASCP 2024)
2024 American Society of Clinical Psychopharmacology | May 28-31 | Miami Beach, FL
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
A Retrospective Study of Real-World Outcomes for Esketamine Nasal Spray Among Patients With Treatment-Resistant Depression
L. Alison McInnes, Kruti Joshi, Gary Kane, Matt Worley, Lisa Harding
Efficacy and Safety of Esketamine Nasal Spray as Monotherapy in Adults with Treatment-Resistant Depression: A Randomized, Double-Blind, Placebo-Controlled Study
Adam Janik, Xin Qiu, Rosanne Lane, Vanina Popova, Wayne C. Drevets, Carla M. Canuso, Dong Jing Fu
Esketamine Nasal Spray Versus Quetiapine for Treatment-Resistant Depression
Kristin Clemens, Amanda Teeple, Benoit Rive, Pushpike Thilakarathne, Yordan Godinov, Noam Kirson, Urvi Desai, Jason Doran, Diab Eid, Alice Qu, Hannah Bowrey, Kruti Joshi
Impact of Duration of Esketamine Nasal Spray Treatment on Change in Depression Symptoms in Real-World Patients
L. Alison McInnes, Kruti Joshi, Gary Kane, Matt Worley, Lisa Harding
Seltorexant, adjunctive to antidepressants, in adults with MDD with insomnia symptoms: results of a double-blind, randomized, placebo-controlled study
Michael E. Thase, Andrew D. Krystal, Ewa Wajs, Joseph M. Trombello, Ryan Kelly, Yun Zhang, Haiyan Xu, John Thipphawong, Sandra Ruschel, Yanina Flossbach, Gahan Pandina, Carla M. Canuso, Thomas Laughren, Wayne C. Drevets
The Association Between Adherence to Esketamine Nasal Spray Therapy Dosing Regimen and Changes in Depressive Symptoms Among Patients With Treatment-Resistant Depression in the United States
Carl D. Marci, Kruti Joshi, Stevan Geoffrey Severtson, Manish K. Jha
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.